15-Deoxy-Δ12,14-Prostaglandin J2Reinforces the Anti-Inflammatory Capacity of Endothelial Cells With a Genetically Determined NO Deficit
- 19 July 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 125 (3) , 282-294
Abstract
Rationale:: Fluid shear stress (FSS) maintains NOS-3 (endothelial NO synthase) expression. Homozygosity for the C variant of the T-786C single-nucleotide polymorphism of theNOS3gene, which solely exists in humans, renders the gene less sensitive to FSS, resulting in a reduced endothelial cell (EC) capacity to generate NO. Decreased bioavailability of NO in the arterial vessel wall facilitates atherosclerosis. Consequently, individuals homozygous for the C variant have an increased risk for coronary heart disease (CHD).Objective:: At least 2 compensatory mechanisms seem to minimize the deleterious effects of this single-nucleotide polymorphism in affected individuals, one of which is characterized herein.Methods and Results:: Human genotyped umbilical vein ECs and THP-1 monocytes were used to investigate the role of 15-deoxy-Δ12,14-prostaglandin J2(15d-PGJ2) in vitro. Its concentration in plasma samples from genotyped patients with CHD and age-matched CHD-free controls was determined using quantitative ultraperformance LC-MS/MS. Exposure of human ECs to FSS effectively reduced monocyte transmigration particularly through monolayers of CC-genotype ECs. Primarily in CC-genotype ECs, FSS elicited a marked rise in COX (cyclooxygenase)-2 and L-PGDS (lipocalin-type prostaglandin D synthase) expression, which appeared to be NO sensitive, and provoked a significant release of 15d-PGJ2over baseline. Exogenous 15d-PGJ2significantly reduced monocyte transmigration and exerted a pronounced anti-inflammatory effect on the transmigrated monocytes by downregulating, for example, transcription of the IL (interleukin)-1β gene (IL1B). Reporter gene analyses verified that this effect is due to binding of Nrf2 (nuclear factor [erythroid-derived 2]–like 2) to 2 AREs (antioxidant response elements) in the proximalIL1Bpromoter. In patients with CHD, 15d-PGJ2plasma levels were significantly upregulated compared with age-matched CHD-free controls, suggesting that this powerful anti-inflammatory prostanoid is part of an endogenous defence mechanism to counteract CHD.Conclusions:: Despite a reduced capacity to form NO, CC-genotype ECs maintain a robust anti-inflammatory phenotype through an enhanced FSS-dependent release of 15d-PGJ2.Keywords
This publication has 37 references indexed in Scilit:
- Large-scale association analysis identifies new risk loci for coronary artery diseaseNature Genetics, 2012
- Genetics of atherosclerosisTrends in Genetics, 2012
- 15-Deoxy-Δ12,14 Prostaglandin J2 Reduces the Formation of Atherosclerotic Lesions in Apolipoprotein E Knockout MicePLOS ONE, 2011
- Peroxisome Proliferator–Activated Receptor-γ Agonists Prevent In Vivo Remodeling of Human Artery Induced by Alloreactive T CellsCirculation, 2011
- The Antioxidant Defense System Keap1-Nrf2 Comprises a Multiple Sensing Mechanism for Responding to a Wide Range of Chemical CompoundsMolecular and Cellular Biology, 2009
- Knockout of the l-pgds gene aggravates obesity and atherosclerosis in miceBiochemical and Biophysical Research Communications, 2009
- 15-Deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) mediates repression of TNF-α by decreasing levels of acetylated histone H3 and H4 at its promoterBiochemical and Biophysical Research Communications, 2007
- Increased Plasma Levels of 15-Deoxy Δ Prostaglandin J 2 Are Associated With Good Outcome in Acute Atherothrombotic Ischemic StrokeStroke, 2005
- 15d-PGJ2 inhibits oxidized LDL-induced macrophage proliferation by inhibition of GM-CSF production via inactivation of NF-κBBiochemical and Biophysical Research Communications, 2004
- The T-786→C Mutation in Endothelial Nitric Oxide Synthase Is Associated With HypertensionHypertension, 2002